Looking to publish in Jto Clinical And Research Reports? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowJTO Clinical and Research Reports is the official open access journal of the International Association for the Study of Lung Cancer. It complements the Journal of Thoracic Oncology by offering a gold open access publication option and particularly publishes Phase I trials, well performed single-arm phase II trials, subset analyses of published trials, impactful retrospective studies, database analysis, large institutional series, high-quality case reports, region-specific clinical trials, subspecialty thoracic oncology studies, and selected high-quality meeting reports.
Looking to publish in Jto Clinical And Research Reports? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Jto Clinical And Research Reports accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Review Articles
Brief Reports
Case Reports
Letters To The Editor
Recent Publications
Patient-Derived Lung Cancer Organoids for Precision Oncology: A Comprehensive Analysis
Donglai Chen, Zewen Sun, Jiangtao Li, Xiaofan Wang, Yongzhong Li, Yiming Mao, Yongbing Chen
Successful Tarlatamab Rechallenge After Recurrent High-Grade CRS in Chromothripsis-Mediated SCLC
Ryan Cheng, Sarah Reddy, Kendra Gee-Rodriguez, Rogelyn Harlan, Chetan Vakkalagadda, Jeremy Cetnar, Rebecca Silbermann, Richard T. Maziarz, Rajat Thawani
Multidisciplinary Approach of Sexual Dysfunction in Patients with Lung Cancer – Spanish Lung Cancer Group (SLCG) Expert Consensus Statement
Aylen Vanessa Ospina-Serrano, Constanza Maximiano-Alonso, Pau Guillén-Sentís, Beatriz Losada, Patricia Cruz-Castellanos, Rafael López-Castro, Begoña Campos-Balea, Eider Azkona-Uribelarrea, Ana Cardeña, Augusto Valdivia, Alejandro Olivares-Hernández, Ana Blasco-Cordellat, María Sereno-Moyano, Delfina Peralta-Tanco, Manuel Dómine, Raquel Romão, Silvia Muñoz-Borrajo, Manuel Garcia-Espantaleon, Augusto Pereira-Sánchez, Esaú Fernández-Pascual, Josep Torremadé-Barreda, Angel Luis Montejo, Miren Larrazabal, Carlos de la Cruz Martin-Romo, Raquel Alvarez-Garcia, Froilan Sánchez, Virginia Calvo, Mariano Provencio-Pulla
Corrigendum to ‘Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System–Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes’
Surbhi Singhal, Caressa Hui, Joel W. Neal, Seema Nagpal, Mohana Roy, Millie Das, Kavitha Ramchandran, Erqi Pollom, Giovanni Selvaggi, Heather A. Wakelee, Nathaniel J. Myall
First-Line Platinum-Based Chemotherapy with Novel Systemic Agents for Unresectable or Metastatic Thymic Epithelial Tumors: A Systematic Review and Meta-Analysis
Gabriela Barbosa e Silva, Lorrany Larisse Costa Rodrigues, Bianca Gonzaga Freitas, Leticia Peixoto Gomes, Mariana Macambira Noronha, Filipe Luís Vasconcelos Visani
Frequently asked questions
How long does it take to publish?
9 days submission to first decision; 47 days submission to decision after review; 111 days submission to acceptance; 6 days acceptance to online publication.
Reformat to Jto Clinical And Research Reports using Livewrite PremiumWhat are the publication costs?
Article Publishing Charge (APC): USD 2,000 (excluding taxes).
Reformat to Jto Clinical And Research Reports using Livewrite Premium